Spot on Microbe Man….
EBS consistently presents a well-grounded perspective of the goings on at Club PPHM. Yet somehow, those who post here 2,3,4,…10 times a day after a taking a few too many tokes off the PPHM crack pipe dismiss him/her as….all together now….”having an agenda”….lovely.
I am all for those who possess an abundance of enthusiasm as to what the BAVI platform can bring to the table as it relates to benefitting both cancer patients and the long-term shareholders. I also find blind allegiance a bit suspect and somehow question those posters motives. You know the ones….those who have consistently announced that this is just another buying opportunity for over a decade and have averaged down by 10% for the 50th time.
Eyebuy’s perspective is just as valid as the next posters….and he/she doesn’t have to write an epistle to make their point…..
Maybe I am mistaken, but didn’t a member of our esteemed board help steer this company named Patriot Scientific smack into the ground? Someone recently posted something to the effect that there wasn’t any issues with this board…..with that kind of resume….I would submit that there is in fact a lot to be leery about. Posters who recently tumbled off the proverbial turnip truck that discount long term shareholders who have a decade or more of history that are questionable of this clan, in fact do have the basis for skepticism. Management never takes any questions on conference calls from retail shareholders and has gone out of their way NOT to promote the company at the detriment of retail shareholders.
Why is it that every time I see articles about immunotherapy cancer drugs, PPHM is almost never mentioned? This platform is way too far along human trials to be not included in the mainstream conversation. Heck…..MD is our #1 promoter of this company….thanks MD….does anyone see anything wrong with this picture? Maybe they would be getting 3,4,5 dollars a share with all this dilution if it weren’t for this mickey mouse operation we still have firmly in place.
I expect that we will finally get our long awaited Phase 1 announcement tomorrow….with the estimated enrollment completion time around 2018 if it follows the imaging trial progress.
The March Madness hoopla ended up being just another PPHM retail shareholder “Rope-a-Dope” as expected.
The deck has always and has always been stacked against small biotech’s like PPHM. We have an awesome compound in BAVI. As I see it today, the foundation that I believe in as it relates to PPHM is a three legged stool…..Thorpe-Garnick-Worsley….period…that is 90% of the bet right now and that is what keeps me here. I believe collectively they will succeed.
Bottom line, we all want BAVI to receive approval as quickly as possible. Just because some question or have issues with the path taken doesn’t make them candidates to have their well thought out views discounted or hiked on.
All IMHO.
